Nanotechnology-enhanced immunotherapy for metastatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanotechnology-enhanced immunotherapy for metastatic cancer

Published:2021-11 Issue:4 Volume:2 Page:100174
ISSN:2666-6758
Container-title:The Innovation
language:en
Short-container-title:The Innovation

Author:

Zhang Peisen,Meng Junli,Li Yingying,Yang Chen,Hou Yi,Tang Wen,McHugh Kevin J.,Jing Lihong^ORCID

Funder

National Key Research and Development Program of China

Cancer Prevention and Research Institute of Texas

National Natural Science Foundation of China

Youth Innovation Promotion Association of the Chinese Academy of Sciences

State Key Laboratory of Luminescence and Applications

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference197 articles.

1. CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer;Tallón de Lara;Nat. Commun.,2021

2. Remodeling of metastatic vasculature reduces lung colonization and sensitizes overt metastases to immunotherapy;He;Cell Rep.,2020

3. Treating metastatic cancer with nanotechnology;Schroeder;Nat. Rev. Cancer,2012

4. Cancer metastases: challenges and opportunities;Guan;Acta Pharm. Sin. B,2015

5. Therapy of primary liver cancer;Feng;The Innovation,2020

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment;Nano Today;2024-10

2. Nanomaterials for bone metastasis;Journal of Controlled Release;2024-09

3. The Synergistic Potential of Hydrogel Microneedles and Nanomaterials: Breaking Barriers in Transdermal Therapy;Macromolecular Bioscience;2024-08-28

4. Cancer immunotherapy and its facilitation by nanomedicine;Biomarker Research;2024-08-03

5. Manipulation of protein corona for nanomedicines;WIREs Nanomedicine and Nanobiotechnology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3